Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 162-165

  Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

BARF1; EBER; Epstein Barr virus; Exosome; Innate immunity; Nasopharyngeal carcinoma; Non coding RNA

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 3;

ANTIBODY TITER; BARF1 GENE; BINDING SITE; CARCINOGENESIS; CONFOCAL LASER MICROSCOPY; EBER GENE; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; FIBROBLAST; GENE FUNCTION; GENETIC ANALYSIS; GOLGI COMPLEX; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; NASOPHARYNX CARCINOMA; NONHUMAN; ONCOGENE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYADENYLATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; HOST-PATHOGEN INTERACTIONS; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; RNA, VIRAL; VIRAL PROTEINS;

EID: 84857793666     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2011.12.007     Document Type: Review

References (46)

1. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields virology 2002, 2655-2700. Wolters Kluwer, Philadelphia, PA. D.M. Knipe, P.M. Howley (Eds.).
2. Zhang C.X., Decaussin G., Daillie J., Ooka T. Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J Virol 1988, 62:1862-1869.
3. Decaussin G., Sbih-Lammali F., De Turenne-Tessier M., Bouguermouh A., Ooka T. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 2000, 60:5584-5588.
4. Seto E., Yang L., Middeldorp J., Sheen T.S., Chen J.Y., Fukayama M., et al. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 2005, 76:82-88.
5. Takada K., Nanbo A. The role of EBERs in oncogenesis. Semin Cancer Biol 2001, 11:461-467.
6. Schwemmle M., Clemens M.J., Hilse K., Pfeifer K., Troster H., Muller W.E., et al. Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. Proc Natl Acad Sci USA 1992, 89:10292-10296.
7. Lerner M.R., Andrews N.C., Miller G., Steitz J.A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981, 78:805-809.
8. Toczyski D.P., Steitz J.A. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J 1991, 10:459-466.
9. Howe J.G., Shu M.D. Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs. J Virol 1988, 62:2790-2798.
10. Clarke P.A., Schwemmle M., Schickinger J., Hilse K., Clemens M.J. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991, 19:243-248.
11. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R., et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990, 62:379-390.
12. Sharp T.V., Schwemmle M., Jeffrey I., Laing K., Mellor H., Proud C.G., et al. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res 1993, 21:4483-4490.
13. Samanta M., Iwakiri D., Kanda T., Imaizumi T., Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 2006, 25:4207-4214.
14. Yoshiyama H., Imai S., Shimizu N., Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 1997, 71:5688-5691.
15. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1998, 72:4371-4378.
16. Iwakiri D., Sheen T.S., Chen J.Y., Huang D.P., Takada K. Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 2005, 24:1767-1773.
17. Tsang C.M., Zhang G., Seto E., Takada K., Deng W., Yip Y.L., et al. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Int J Cancer 2010, 127:1570-1583.
18. Samanta M., Iwakiri D., Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008, 27:4150-4160.
19. - RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J 2000, 19:6742-6750.
20. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
21. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
22. Liu F., Gu J. Retinoic acid inducible gene-I, more than a virus sensor. Protein Cell 2011, 2:351-357.
23. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
24. Iwakiri D., Zhou L., Samanta M., Matsumoto M., Ebihara T., Seya T., et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009, 206:2091-2099.
25. Kapsogeorgou E.K., Abu-Helu R.F., Moutsopoulos H.M., Manoussakis M.N. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005, 52:1517-1521.
26. Yamamoto N., Takizawa T., Iwanaga Y., Shimizu N., Yamamoto N. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett 2000, 484:153-158.
27. Nanbo A., Inoue K., Adachi-Takasawa K., Takada K. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 2002, 21:954-965.
28. - RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J Virol 2005, 79:12280-12285.
29. Gilligan K.J., Sato H., Rajadurai P., Busson P., Young L., Rickinson A., et al. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 1990, 64:4948-4956.
30. Sadler R.H., Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 1995, 69:1132-1141.
31. Zhang J., Chen H., Weinmaster G., Hayward S.D. Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J Virol 2001, 75:2946-2956.
32. Ooka T. BARF-1 gene as an EBV encoded oncogene. Epstein-Barr Virus Rep 2001, 8:177-182.
33. Wei M.X., Ooka T. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J 1989, 8:2897-2903.
34. Wei M.X., De Turenne-Tessier M., Decaussin G., Benet G., Ooka T. Establishment of a monkey epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 1997, 14:3073-3081.
35. Wei M.X., Moulin J.C., Decaussin G., Berger F., Ooka T. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res 1994, 54:1843-1848.
36. Sheng W., Decaussin G., Ligout A., Takada K., Ooka T. Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol 2003, 77:3859-3865.
37. Wang Q., Tsao S.W., Ooka T., Nicholls J.M., Cheung H.W., Fu S., et al. Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett 2006, 238(1):90-103.
38. Sall A., Caserta S., Jolicoeur P., Franqueville L., De Turenne-Tessier M., Ooka T. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein. Oncogene 2004, 23:4938-4944.
39. Wiech T., Nikolopoulos E., Lassman S., Heidt T., Schöpflin A., Sarbia M., et al. Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer. Virchows Arch 2008, 452:621-627.
40. Strockbine L.D., Cohen J.I., Farrah T., Lyman S.D., Wagener F., DuBose R.F., et al. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 1998, 72:4015-4021.
41. Sapi E., Flick M.B., Gilmore-Hebert M., Rodov S., Kacinski B.M. Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids. Oncogene 1995, 10:529-542.
42. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-739.
43. Brink A.A., Vervoort M.B., Middeldorp J.M., Meijer C.J., van den Brule A.J. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. J Clin Microbiol 1998, 36:3164-3169.
44. zur Hausen A., Brink A.A.T.P., Craanen M.E., Middeldorp J.M., Meijer C.J.L.M., Vandenbrule A.J.C. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 2000, 60:2745-2748.
45. Stevens S.J., Verkuijlen S.A., Hariwiyanto B., Harijadi, Paramita D.K., Fachiroh J., et al. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer 2006, 119:608-614.
46. Seto E., Ooka T., Middeldorp J., Takada K. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res 2008, 68:1030-1036.